What does Third Arc Bio do?
Third Arc Bio is an immunology and inflammation-focused biotechnology company developing targeted immune therapeutics across oncology and inflammatory disease programs.
Explore Third Arc Bio careers and hiring status. Find jobs at Third Arc Bio and official application links when roles are open. Funding stage: Series A. Headcount: 11-50. Third Arc Bio is an immunology and inflammation-focused biotechnology company developing targeted immune therapeutics across oncology and inflammatory disease programs.
This page summarizes open roles, company profile signals, and official application paths so candidates can quickly evaluate fit before applying. Use the role list below to identify team focus, review location patterns, and jump to source listings. For broader comparison across the market, continue to the full company directory and jobs explorer.
Third Arc Bio is a Series A stage AI startup, founded in 2022, with $217M in total disclosed funding. Its most recent round was a $52M Series A in Feb 2026. It has no open roles listed at the moment; new Third Arc Bio openings are tracked daily. Source: Fast AI Jobs company dataset, updated Aug 2026.
Company profile last updated on Aug 12, 2026.
Third Arc Bio careers and hiring status: no open roles are currently listed here, but you can review the company profile and check the official career page for the latest openings. Official careers page
Third Arc Bio is an biotech company. Third Arc Bio is an immunology and inflammation-focused biotechnology company developing targeted immune therapeutics across oncology and inflammatory disease programs.
Open positions
Check the official career page, browse adjacent companies, or subscribe for new openings.
Candidate questions
Third Arc Bio is an immunology and inflammation-focused biotechnology company developing targeted immune therapeutics across oncology and inflammatory disease programs.
Third Arc Bio does not have open roles listed on our platform right now. Visit the official company website or career page for the latest openings, or subscribe to get notified when new roles are posted.
Third Arc Bio has raised $217M in total. The latest known stage is Series A.
Third Arc Bio reports an employee count of 11-50.
Third Arc Bio was founded in 2022.
Third Arc Bio is associated with Biotech, Healthcare, Machine Learning, Data Platform, B2B SaaS.
Company context
Third Arc Bio is a Series A stage AI startup, founded in 2022, with $217M in total disclosed funding. Its most recent round was a $52M Series A in Feb 2026. It has no open roles listed at the moment; new Third Arc Bio openings are tracked daily. Source: Fast AI Jobs company dataset, updated Aug 2026.